arrow
返回
D

Douglas Yee

Masonic Cancer Center

83H指数
581论文数
2.6W被引数
收录论文 226
发表时间
err分享
err收藏
Tumor-specific lncRNA IGF1R-AS1 trans-regulates chromatin interactions associated with oncogenic MYC signaling肿瘤特异性lncRNA IGF1R-AS1跨调控与致癌性MYC信号通路相关的染色质相互作用
err2026-03-19
err0
errOAAI
errYongyong Yang; Ting-You Wang; Joshua Fry; Yingming Li; Qingshu Meng; Qingxiang Guo; Nathan E. Patchen; Kyle H. White; Abhirami Ramakrishnan; Yanan Ren; Qianru Li; Xingxing Zhang; Taufeeque Ali; Courtney Dawes; Stamatina Fragkogianni; Parker Irvin; Sk Kayum Alam; Luke H. Hoeppner; Xihong Zhang; Douglas Yee; Adam B. Weiner; Edward M. Schaeffer; Yang Liu; Xiaoyang Zhang; Scott M. Dehm; Qi Cao; Rendong Yang
err分享
err收藏
RISE UP for breast cancer 2024: conference highlights & takeaways
err2026-01-06
err0
errOAAI
errTaylor Glatt; Katherine Leggat-Barr; Nandini Seth; Diane Heditsian; Laura van ’t Veer; Lajos Pusztai; Elissa Price; Nola Hylton; Silvia Formenti; Hope Rugo; Laura Fejerman; Adetunji T. Toriola; Carol Fabian; Andrea De Censi; Daniel Grossman; Olufunmilayo Olopade; Andrea Jackson; Sara Horton; Kim Rhoads; Carol Lange; Virginia Borges; Elizabeth Garner; Judy Garber; Douglas Yee; Laura Esserman
err分享
err收藏
ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical TrialASO视觉摘要:新辅助化疗后至手术时间对乳腺癌结局的影响:一项基于I-SPY 2临床试验入组患者的研究
err2025-08-29
err0
PREAI
errJulie Van Hassel; Katrina Dimitroff; Christina Yau; Rita Mukhtar; Judy C. Boughey; Velle Ladores; Marissa M. Howard-McNatt; Nora Jaskowiak; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola Hylton; W. Fraser Symmans; Laura van’t Veer; Hope Rugo; Laura J. Esserman; Rebecca Shatsky; Claudine Isaacs; Henry Kuerer; Anne M. Wallace; Nicolas Prionas; Jennifer Tseng; Chantal R. Reyna; Neil Taunk; Susan Kesmodel; Marie C. Lee; Jana Fox; Mara A. Piltin; Julia Tchou; Cletus A. Arciero; Lauren M. Postlewait; Candice Sauder; Roshni Rao
err分享
err收藏
Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial新辅助化疗后手术时间对乳腺癌结局的影响:一项基于I-SPY 2临床试验入组患者的研究
err2025-08-23
err0
PREAI
errJulie Van Hassel; Katrina Dimitroff; Christina Yau; Rita Mukhtar; Judy C. Boughey; Velle Ladores; Marissa M. Howard-McNatt; Nora Jaskowiak; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola Hylton; W. Fraser Symmans; Laura van’t Veer; Hope Rugo; Laura J. Esserman; Rebecca Shatsky; Claudine Isaacs; Henry Kuerer; Anne M. Wallace; Nicolas Prionas; Jennifer Tseng; Chantal R. Reyna; Neil Taunk; Susan Kesmodel; Marie C. Lee; Jana Fox; Mara A. Piltin; Julia Tchou; Cletus A. Arciero; Lauren M. Postlewait; Candice Sauder; Roshni Rao
err分享
err收藏
ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical TrialASO视觉摘要:新辅助化疗对浸润性小叶乳腺癌手术结果及淋巴结阴性转化率的影响:根据I-SPY2临床试验中分子高风险肿瘤的组织学亚型进行分析
err2025-08-23
err0
PREAI
errRita A. Mukhtar; Katrina Dimitroff; Christina Yau; A. Jo Chien; Eileen P. Connolly; Marissa Howard-McNatt; Roshni Rao; Velle Ladores; Mehra Golshan; Candice A. Sauder; Kamran Ahmed; Rachael Lancaster; Jana Fox; Lily Gutnik; M. Catherine Lee; Julia Tchou; Nicolas Prionas; Cletus A. Arciero; Chantal Reyna; Henry Kuerer; Kayla Switalla; Neil Taunk; Todd M. Tuttle; Meena S. Moran; Lauren M. Postlewait; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola Hylton; W. Fraser Symmans; Hope S. Rugo; Rebecca Shatsky; Claudine Isaacs; Laura J. Esserman; Laura van ‘t Veer; Judy C. Boughey
err分享
err收藏
Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY Trial接受奈拉替尼或曲妥珠单抗治疗患者的血清HER2检测:I-SPY试验分析
err2025-07-27
err0
errOAAI
errMark Hensley; Justin Lengfeld; Steven Stoesz; Michelle Edwards; Franklin Pass; Gillian L. Hirst; Lamorna Brown-Swigart; Laura van ‘t Veer; Laura J. Esserman; Heather Beckwith; Douglas Yee†
err分享
err收藏
Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial新辅助化疗对浸润性小叶乳腺癌手术结果及淋巴结阴性转化影响的评估:基于I-SPY2临床试验中按组织学亚型分析分子高风险肿瘤
err2025-07-24
err0
errOAAI
errRita A. Mukhtar; Katrina Dimitroff; Christina Yau; A. Jo Chien; Eileen P. Connolly; Marissa Howard-McNatt; Roshni Rao; Velle Ladores; Mehra Golshan; Candice A. Sauder; Kamran Ahmed; Rachael Lancaster; Jana Fox; Lily Gutnik; M. Catherine Lee; Julia Tchou; Nicolas Prionas; Cletus A. Arciero; Chantal Reyna; Henry Kuerer; Kayla Switalla; Neil Taunk; Todd M. Tuttle; Meena S. Moran; Lauren M. Postlewait; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola Hylton; W. Fraser Symmans; Hope S. Rugo; Rebecca Shatsky; Claudine Isaacs; Laura J. Esserman; Laura van’t Veer; Judy C. Boughey
err分享
err收藏
Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial在多中心新辅助I-SPY2试验中,基于自我识别种族的腋窝手术管理差异
err2025-07-23
err0
errOAAI
errMandeep Kaur; Katrina Dimitroff; Judy C. Boughey; Laura J. Esserman; Christina Yau; Julia Tchou; Astrid Quirarte; Marie Catherine Lee; Marissa M. Howard-McNatt; Kayla Switalla; Henry Kuerer; Candice Sauder; Lauren M. Postlewait; Cletus Arciero; Roshni Rao; Anne Wallace; Chantal Reyna; Kamran Ahmed; Lily Gutnik; Neil Taunk; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola M. Hylton; W. Fraser Symmans; Hope S. Rugo; Rebecca A. Shatsky; Claudine Isaacs; Sonali Rudra; Paula Pohlmann; Cheryl Ewing; Jasmine Wong; Michael Alvarado; Nora Jaskowiak; Nicolas Prionas; Mehra Golshan; Mara A. Piltin; Olufunmilayo I. Olopade; Rita A. Mukhtar
err分享
err收藏
Pathologic complete response (pCR) rates for patients with HRD/HER2L high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial在I-SPY2临床试验中,根据临床和分子特征,HRD/HER2L高风险早期乳腺癌(EBC)患者的病理完全缓解(pCR)率。
err2025-02-01
err2
PREAI
errHuppert, L. A.; Wolf, D.; Yau, C.; Brown-Swigart, L.; Hirst, G. L.; Isaacs, C.; Pusztai, L.; Pohlmann, P. R.; Demichele, A.; Shatsky, R.; Yee, D.; Thomas, A.; Nanda, R.; Perlmutter, J.; Heditsian, D.; Hylton, N.; Symmans, F.; van't Veer, L. J.; Esserman, L.; Rugo, H. S.
err分享
err收藏
A roadmap to reduce the incidence and mortality of breast cancer by rethinking our approach to women's health (Nov, 10.1007/s10549-024-07522-4, 2024)
err2024-12-20
err0
errOAAI
errLeggat-Barr, Katherine; Yee, Douglas; Duralde, Erin; Hodge, Caroline; Borges, Virginia; Baxter, Molly; Valdez, Jessica; Morgan, Tamandra; Garber, Judy; Esserman, Laura
err分享
err收藏
Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer
err2024-12-03
err0
errOAAI
errRugo, Hope S.; Campbell, Mike; Yau, Christina; Jo Chien, A.; Wallace, Anne M.; Isaacs, Claudine; Boughey, Judy C.; Han, Hyo S.; Buxton, Meredith; Clennell, Julia L.; Asare, Smita M.; Steeg, Katherine; Wilson, Amy; Singhrao, Ruby; Matthews, Jeffrey B.; Perlmutter, Jane; Fraser Symmans, W.; Hylton, Nola M.; Demichele, Angela M.; Yee, Douglas; Van't Veer, Laura J.; Berry, Donald A.; Esserman, Laura J.
err分享
err收藏
A roadmap to reduce the incidence and mortality of breast cancer by rethinking our approach to women's health
err2024-11-12
err2
errOAAI
errLeggat-Barr, Katherine; Yee, Douglas; Duralde, Erin; Hodge, Caroline; Borges, Virginia; Baxter, Molly; Valdez, Jessica; Morgan, Tamandra; Garber, Judy; Esserman, Laura
err分享
err收藏
Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer
err2024-11-01
err0
errOAAI
errCampbell, Michael J.; Wolf, Denise M.; Yau, Christina; Brown-Swigart, Lamorna; Wulfkuhle, Julie; Gallagher, Isela R.; Zhu, Zelos; Bolen, Jennifer; Vandenberg, Scott; Hoyt, Clifford; Mori, Hidetoshi; Borowsky, Alexander; Sit, Laura; Perlmutter, Jane; Asare, Smita M.; Nanda, Rita; Liu, Minetta C.; Yee, Douglas; Demichele, Angela M.; Hylton, Nola M.; Pusztai, Lajos; Berry, Donald A.; Hirst, Gillian L.; Petricoin, Emanuel F.; van't Veer, Laura; Esserman, Laura
err分享
err收藏
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trialDatopotamab-deruxtecan治疗早期乳腺癌: 序贯多重分配随机I-SPY2.2 2期试验
err2024-09-14
err1
PREAI
errKhoury, Katia; Meisel, Jane L.; Yau, Christina; Rugo, Hope S.; Nanda, Rita; Davidian, Marie; Tsiatis, Butch; Chien, A. Jo; Wallace, Anne M.; Arora, Mili; Rozenblit, Mariya; Hershman, Dawn L.; Zimmer, Alexandra; Clark, Amy S.; Beckwith, Heather; Elias, Anthony D.; Stringer-Reasor, Erica; Boughey, Judy C.; Nangia, Chaitali; Vaklavas, Christos; Omene, Coral; Albain, Kathy S.; Kalinsky, Kevin M.; Isaacs, Claudine; Tseng, Jennifer; Torres, Evanthia T. Roussos; Thomas, Brittani; Thomas, Alexandra; Sanford, Amy; Balassanian, Ronald; Ewing, Cheryl; Yeung, Kay; Sauder, Candice; Sanft, Tara; Pusztai, Lajos; Trivedi, Meghna S.; Outhaythip, Ashton; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Beedle, Carolyn; Perlmutter, Jane; Pohlmann, Paula; Shatsky, Rebecca A.; Demichele, Angela; Yee, Douglas; van't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J.
err分享
err收藏
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trialDatopotamab-deruxtecan联合durvalumab治疗早期乳腺癌: 序贯多重分配随机I-SPY2.2 2期试验
err2024-09-14
err4
PREAI
errShatsky, Rebecca A.; Trivedi, Meghna S.; Yau, Christina; Nanda, Rita; Rugo, Hope S.; Davidian, Marie; Tsiatis, Butch; Wallace, Anne M.; Chien, A. Jo; Stringer-Reasor, Erica; Boughey, Judy C.; Omene, Coral; Rozenblit, Mariya; Kalinsky, Kevin; Elias, Anthony D.; Vaklavas, Christos; Beckwith, Heather; Williams, Nicole; Arora, Mili; Nangia, Chaitali; Torres, Evanthia T. Roussos; Thomas, Brittani; Albain, Kathy S.; Clark, Amy S.; Falkson, Carla; Hershman, Dawn L.; Isaacs, Claudine; Thomas, Alexandra; Tseng, Jennifer; Sanford, Amy; Yeung, Kay; Boles, Sarah; Chen, Yunni Yi; Huppert, Laura; Jahan, Nusrat; Parker, Catherine; Giridhar, Karthik; Howard, Frederick M.; Blackwood, M. Michele; Sanft, Tara; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Heditsian, Diane; Lestage, Barbara; Perlmutter, Jane; Pohlmann, Paula; Demichele, Angela; Yee, Douglas; van 't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J.
err分享
err收藏
Mutational impact of APOBEC3A and APOBEC3B in a human cell line
err2024-05-02
err0
PREAI
errCarpenter, Michael; Temiz, Nuri; Ibrahim, Mahmoud; Jarvis, Matthew; Brown, Margaret; Argyris, Prokopios; Brown, William; Yee, Douglas; Harris, Reuben
err分享
err收藏
Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time
err2024-05-01
err0
errOAAI
errShaaban, Adnan; Petersen, Ashley; Beckwith, Heather; Florea, Natalia; Potter, David A.; Yee, Douglas; Vogel, Rachel I.; Duprez, Daniel; Blaes, Anne H.
err分享
err收藏
err分享
err收藏
Association of antibiotic exposure with residual cancer burden in HER2-negative early stage breast cancer
err2024-03-26
err1
errOAAI
errKulkarni, Amit A.; Jain, Aditya; Jewett, Patricia I.; Desai, Nidhi; Van 't Veer, Laura; Hirst, Gillian; Yee, Douglas; Blaes, Anne H.
err分享
err收藏